Comparison of the efficacy of 3 drugs in prevention of side effects of radioiodine therapy in thyroid cancer patients
Phase 2
- Conditions
- Thyroid carcinoma.Malignant neoplasm of thyroid gland
- Registration Number
- IRCT2013061713705N1
- Lead Sponsor
- Vice chancellor for research, Shahid Beheshti University Of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 85
Inclusion Criteria
1- All the patients affected by differentiated thyroid carcinoma.
2- All the patients for whom total thyroidectomy is done.
Exclusion criteria:
1- Pregnant women
2- Lactating women
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ausea. Timepoint: Daily for 3 days. Method of measurement: Check list(Mild, Moderate, and severe).;Vomiting. Timepoint: Daily for 3 days. Method of measurement: check list (has, or has not).
- Secondary Outcome Measures
Name Time Method